These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 17433507)

  • 1. Recombinant murine gammaherpesvirus 68 (MHV-68) as challenge virus to test efficacy of vaccination against chronic virus infections in the mouse model.
    El-Gogo S; Staib C; Meyr M; Erfle V; Sutter G; Adler H
    Vaccine; 2007 May; 25(20):3934-45. PubMed ID: 17433507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model.
    El-Gogo S; Staib C; Lasarte JJ; Sutter G; Adler H
    J Gene Med; 2008 Feb; 10(2):177-86. PubMed ID: 18076128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of murine gamma-herpesvirus infection.
    Nash AA; Dutia BM; Stewart JP; Davison AJ
    Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):569-79. PubMed ID: 11313012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with recombinant modified vaccinia virus Ankara prevents the onset of intestinal allergy in mice.
    Bohnen C; Wangorsch A; Schülke S; Nakajima-Adachi H; Hachimura S; Burggraf M; Süzer Y; Schwantes A; Sutter G; Waibler Z; Reese G; Toda M; Scheurer S; Vieths S
    Allergy; 2013 Aug; 68(8):1021-8. PubMed ID: 23909913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apparent MHC-independent stimulation of CD8+ T cells in vivo during latent murine gammaherpesvirus infection.
    Coppola MA; Flaño E; Nguyen P; Hardy CL; Cardin RD; Shastri N; Woodland DL; Blackman MA
    J Immunol; 1999 Aug; 163(3):1481-9. PubMed ID: 10415050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with inactivated murine gammaherpesvirus 68 strongly limits viral replication and latency and protects type I IFN receptor knockout mice from a lethal infection.
    Aricò E; Robertson KA; Belardelli F; Ferrantini M; Nash AA
    Vaccine; 2004 Mar; 22(11-12):1433-40. PubMed ID: 15063566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with a Modified Vaccinia Virus Ankara-based vaccine protects mice from allergic sensitization.
    Albrecht M; Suezer Y; Staib C; Sutter G; Vieths S; Reese G
    J Gene Med; 2008 Dec; 10(12):1324-33. PubMed ID: 18816482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal immunization with recombinant adenoviral vectors expressing murine gammaherpesvirus-68 genes M2 and M3 can reduce latent viral load.
    Hoegh-Petersen M; Thomsen AR; Christensen JP; Holst PJ
    Vaccine; 2009 Nov; 27(48):6723-30. PubMed ID: 19748577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ORF6 and ORF61 Expressing MVA Vaccines Impair Early but Not Late Latency in Murine Gammaherpesvirus MHV-68 Infection.
    Samreen B; Tao S; Tischer K; Adler H; Drexler I
    Front Immunol; 2019; 10():2984. PubMed ID: 31921215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHV-68 producing mIFNα1 is severely attenuated in vivo and effectively protects mice against challenge with wt MHV-68.
    Aricò E; Monque DM; D'Agostino G; Moschella F; Venditti M; Kalinke U; Allen DJ; Stewart JP; Nash AA; Belardelli F; Ferrantini M
    Vaccine; 2011 May; 29(23):3935-44. PubMed ID: 21481326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant MVA expressing secreted glycoprotein D of BoHV-1 induces systemic and mucosal immunity in animal models.
    Ferrer MF; Del Médico Zajac MP; Zanetti FA; Valera AR; Zabal O; Calamante G
    Viral Immunol; 2011 Aug; 24(4):331-9. PubMed ID: 21830904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of mouse mammary glands to murine gammaherpesvirus 72 (MHV-72) infection: evidence of MHV-72 transmission via breast milk.
    Raslova H; Berebbi M; Rajcani J; Sarasin A; Matis J; Kudelova M
    Microb Pathog; 2001 Aug; 31(2):47-58. PubMed ID: 11453700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 T cell control of acute and latent murine gammaherpesvirus infection requires IFNgamma.
    Sparks-Thissen RL; Braaten DC; Hildner K; Murphy TL; Murphy KM; Virgin HW
    Virology; 2005 Aug; 338(2):201-8. PubMed ID: 15961135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of CD8+ T cell responses by Yersinia vaccine carrier strains.
    Wiedig CA; Kramer U; Garbom S; Wolf-Watz H; Autenrieth IB
    Vaccine; 2005 Oct; 23(42):4984-98. PubMed ID: 15985316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.
    Kreijtz JH; Suezer Y; van Amerongen G; de Mutsert G; Schnierle BS; Wood JM; Kuiken T; Fouchier RA; Lower J; Osterhaus AD; Sutter G; Rimmelzwaan GF
    J Infect Dis; 2007 Jun; 195(11):1598-606. PubMed ID: 17471429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion and activation of NK cell populations in a gammaherpesvirus infection.
    Thomson RC; Petrik J; Nash AA; Dutia BM
    Scand J Immunol; 2008 May; 67(5):489-95. PubMed ID: 18363592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus reconstituted from infectious bacterial artificial chromosome (BAC)-cloned murine gammaherpesvirus 68 acquires wild-type properties in vivo only after excision of BAC vector sequences.
    Adler H; Messerle M; Koszinowski UH
    J Virol; 2001 Jun; 75(12):5692-6. PubMed ID: 11356978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4.
    McCurdy LH; Rutigliano JA; Johnson TR; Chen M; Graham BS
    J Virol; 2004 Nov; 78(22):12471-9. PubMed ID: 15507634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies.
    Weyer J; Rupprecht CE; Mans J; Viljoen GJ; Nel LH
    Vaccine; 2007 May; 25(21):4213-22. PubMed ID: 17434244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
    Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G
    J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.